Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
30
BMEZ Quote, Financials, Valuation and Earnings
Last price:
$14.94
Seasonality move
:
-7.12%
Day range:
$14.62 - $15.18
52-week range:
$14.38 - $16.59
Dividend yield:
1.19%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
512.3K
Avg. volume:
411.8K
1-year change:
1.22%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingBlackRock Health Sciences Trust II has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, BlackRock Health Sciences Trust II has an estimated downside of -- from its current price of $14.89.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $14.89.
Fair Value
-
According to the consensus of 0 analysts, BlackRock Health Sciences Trust II has -- downside to fair value with a price target of -- per share.
BMEZ vs. S&P 500
-
Over the past 5 trading days, BlackRock Health Sciences Trust II has underperformed the S&P 500 by -4.15% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
BlackRock Health Sciences Trust II does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
BlackRock Health Sciences Trust II has grown year-over-year revenues for 0 quarters straight. In the most recent quarter BlackRock Health Sciences Trust II reported revenues of --.
Earnings Growth
-
BlackRock Health Sciences Trust II has grown year-over-year earnings for 0 quarters straight. In the most recent quarter BlackRock Health Sciences Trust II reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-25 | 2023-12-25 | 2023-12-25 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-25 | 2021-12-25 | 2022-12-25 | 2023-12-25 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-25 | 2023-12-25 | 2023-12-25 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
BMEZ
Sector
Market Cap
--
--
Price % of 52-Week High
89.75%
--
Dividend Yield
1.19%
--
Shareholder Yield
--
--
1-Year Price Total Return
1.22%
--
Beta (5-Year)
--
--
Dividend yield:
1.19%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$14.96
200-day SMA
Sell
Level
$15.54
Bollinger Bands (100)
Sell
Level
15.35 - 15.99
Chaikin Money Flow
Sell
Level
-36.5M
20-day SMA
Sell
Level
$15.36
Relative Strength Index (RSI14)
Sell
Level
38.52
ADX Line
Buy
Level
17.8
Williams %R
Neutral
Level
-74.1259
50-day SMA
Sell
Level
$15.49
MACD (12, 26)
Sell
Level
-0.21
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Sell
Level
-5.3M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
Stock Forecast FAQ
In the current month, BMEZ has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BMEZ average analyst price target in the past 3 months is --.
-
Where Will BlackRock Health Sciences Trust II Stock Be In 1 Year?
According to analysts, the consensus estimate is that BlackRock Health Sciences Trust II share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About BlackRock Health Sciences Trust II?
Analysts are divided on their view about BlackRock Health Sciences Trust II share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that BlackRock Health Sciences Trust II is a Sell and believe this share price will rise from its current level to --.
-
What Is BlackRock Health Sciences Trust II's Price Target?
The price target for BlackRock Health Sciences Trust II over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BMEZ A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for BlackRock Health Sciences Trust II is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BMEZ?
You can purchase shares of BlackRock Health Sciences Trust II via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase BlackRock Health Sciences Trust II shares.
-
What Is The BlackRock Health Sciences Trust II Share Price Today?
BlackRock Health Sciences Trust II was last trading at $14.94 per share. This represents the most recent stock quote for BlackRock Health Sciences Trust II. Yesterday, BlackRock Health Sciences Trust II closed at $14.89 per share.
-
How To Buy BlackRock Health Sciences Trust II Stock Online?
In order to purchase BlackRock Health Sciences Trust II stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
